Vir Biotechnology (VIR)
NASDAQ:VIR
US Market
Holding VIR?
Track your performance easily

Vir Biotechnology (VIR) Financial Statements

1,189 Followers

Vir Biotechnology Financial Overview

Vir Biotechnology's market cap is currently ―. The company's EPS TTM is $-4.013; its P/E ratio is -2.33; Vir Biotechnology is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.90. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 9.60M$ 2.64M$ 3.80M$ 46.71M$ -12.54M
Gross Profit$ 8.80M$ 2.60M$ 3.80M$ 44.80M$ 15.79M
EBIT-$ -166.59M$ -197.62M$ -143.19M$ -151.64M
EBITDA--$ -195.90M$ -146.91M$ -157.31M
Net Income Common Stockholders$ -115.97M$ -163.41M$ -194.78M$ -140.90M$ -101.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.51B$ 1.69B$ 1.85B$ 2.24B$ 2.38B
Total Assets$ 1.92B$ 2.04B$ 2.24B$ 2.67B$ 2.80B
Total Debt$ 111.67M$ 114.12M$ 117.81M$ 121.46M$ 123.84M
Net Debt$ -1.40B$ -1.57B$ -1.73B$ -2.12B$ -2.26B
Total Liabilities$ 328.82M$ 369.81M$ 433.67M$ 695.13M$ 724.13M
Stockholders Equity$ 1.59B$ 1.68B$ 1.81B$ 1.97B$ 2.08B
Cash Flow-
Free Cash Flow--$ -398.72M$ -132.65M$ -15.60M
Operating Cash Flow$ -107.93M$ -155.83M$ -389.27M$ -125.78M$ -15.60M
Investing Cash Flow$ -104.81M$ -58.95M$ 230.31M$ 98.08M-
Financing Cash Flow$ 1.68M$ 277.00K$ 3.18M$ 2.34M-
Currency in USD

Vir Biotechnology Earnings and Revenue History

Vir Biotechnology Debt to Assets

Vir Biotechnology Cash Flow

Vir Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis